Johns Hopkins Joins the TBEL Consortia
- Tony S. Vines
- Feb 27, 2024
- 1 min read
Dr. Angelo De Marzo, Dr. Srinivasan Yegnasubramanian, et al. with the Johns Hopkins TBEL Center are studying the role of inflammation and immune evasion in the development of prostate cancer. They are working to identify new ways to prevent and intercept the growth of aggressive tumors.
News and Updates related to the Translational and Basic Science Research in Early Lesions (TBEL) Program supported by DCB and the NCI Division of Cancer Prevention.
Comments